Urodynamix currently has two technologies in its portfolio. It’s lead technology, URO-NIRS, and the AVID System.
URO-NIRS – New Non-Invasive Urodynamics
Urodynamix is currently in the early stages of commercializing breakthrough diagnostic technology for bladder conditions, specifically urinary incontinence (UI). The technology, uses near infrared spectroscopy (NIRS), to provide non-invasive testing and diagnosis of diseases of the bladder for patients who experience urinary incontinence and bladder dysfunction.
UI is a widespread condition with severe economic and psychosocial impact. The World Health Organization estimates that UI affects 200 million people worldwide, while the National Institute for Health estimates that UI direct and indirect costs are $16 billion annually in the United States. UI affects men, women and children of all ages. UI is age related but primarily caused by the affects of childbirth in women and prostate diseases in men.
AVID System
The AVID System is a non-invasive technology invented by the BC Cancer Agency and UBC medical physicists, and commercialized by Urodynamix. It is a sophisticated quality assurance system for IMRT (Intensity Modulated Radiation Therapy) which allows the verification of complex radiation treatment plans prior to treating patients. |
